BusinessMelinta Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Topical RadezolidBy Nasdaq OMXFeb 28, 2017, 1:02 PM UTC
BusinessMelinta Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Topical RadezolidBy Nasdaq OMXFeb 28, 2017, 1:02 PM UTC